Evercore Wealth Management’s Standard BioTools LAB Stock Holding History

Evercore Wealth Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Hold	125,000	–	–	﹤0.01%	422
2026 Q1	$115K	Hold	125,000	–	–	﹤0.01%	406
2025 Q4	$160K	Hold	125,000	–	–	﹤0.01%	402
2025 Q3	$163K	Hold	125,000	–	–	﹤0.01%	405
2025 Q2	$150K	Hold	125,000	–	–	﹤0.01%	398
2025 Q1	$135K	Hold	125,000	–	–	﹤0.01%	406
2024 Q4	$219K	Buy	+125,000	New	+$233K	﹤0.01%	390

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Evercore Wealth Management's LAB Position: Q2 2026 in Review

Evercore Wealth Management held its Standard BioTools (LAB) position steady in Q2 2026 at 125,000 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Evercore Wealth Management first reported a position in LAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $219K in Q4 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Evercore Wealth Management held 125,000 shares of Standard BioTools worth $103K as of Q2 2026.
Evercore Wealth Management left its Standard BioTools share count unchanged in Q2 2026.
Standard BioTools made up ﹤0.01% of Evercore Wealth Management's portfolio in Q2 2026, its #422 holding.
Evercore Wealth Management first reported a position in Standard BioTools in Q4 2024 and has held it in 7 quarters since.
Evercore Wealth Management's Standard BioTools position peaked at $219K in Q4 2024.
143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.